High blood pressure screening in pharmacies during May Measurement Month campaigns in Switzerland.
Aikaterini DamianakiKenji TheilerThomas BeaneyWei WangMichel BurnierGrégoire WuerznerPublished in: Blood pressure (2022)
HT screening campaigns in pharmacies recruits mainly women. It helps the detection of untreated hypertensive participants and uncontrolled treated participants. Our data suggest that the average BP should be calculated on the second and third measurements due to a significant first measure effect in pharmacies measurement. SummaryHigh blood pressure (BP) is a major global public health issue as the leading risk factor of global death.World-wide initiatives like May Measurement Month (MMM) aim to screen thousands of people each year to raise awareness of hypertension (HT).Switzerland participated in MMM 2017-2019 and screened more than 2500 participants in pharmacies.When adopting the recent proposed thresholds of HT diagnosis in pharmacies (ESH 2021 > 135/85 mmHg), HT prevalence in Switzerland is high (38.3%) with only 2/3 of treated hypertensive achieving the BP goals.Women are more likely to participate in such campaigns taking place in pharmacies.A first measurement effect (FME) was also present in pharmacies, highlighting that taking three BP measurements in pharmacies and discarding the first should be also considered in the pharmacy setting.Involving a routine pharmacy-based health care of patients would help to identify more hypertensive patients and uncontrolled treated patients, who may not have had access to BP measurement.
Keyphrases
- blood pressure
- hypertensive patients
- public health
- healthcare
- newly diagnosed
- heart rate
- risk factors
- end stage renal disease
- ejection fraction
- chronic kidney disease
- polycystic ovary syndrome
- type diabetes
- machine learning
- electronic health record
- high throughput
- insulin resistance
- pregnant women
- big data
- pregnancy outcomes
- adipose tissue
- peritoneal dialysis
- single cell
- global health
- sensitive detection